Anastomotic Leak
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 programSpanish National Registry of ANAstomotic Leakage in CAncer of the REctum (ANACARE)N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Hamilton medicalStream™ Platform
Johnson & JohnsonSpanish National Registry of ANAstomotic Leakage in CAncer of the REctum (ANACARE)
Clinical Trials (2)
Total enrollment: 2,000 patients across 2 trials
Economic Evaluation of Stream™ Platform
Start: Dec 2023Est. completion: Jun 2026
Phase 3Active Not Recruiting
NCT02634112Johnson & JohnsonSpanish National Registry of ANAstomotic Leakage in CAncer of the REctum (ANACARE)
Spanish National Registry of ANAstomotic Leakage in CAncer of the REctum (ANACARE)
Start: Jan 2016Est. completion: Nov 20162,000 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space